Citation 176642

CHANG,IM: HUR,SO: LEE,ES:. (1985). BIOLOGICAL ACTIVITIES OF IRIDOID GLYCOSIDES I. ANTIMICROBIAL ACTIVITIES AND INHIBITION OF RNA AND PROTEIN SYNTHESIS.. ()

Citation Details

Title	BIOLOGICAL ACTIVITIES OF IRIDOID GLYCOSIDES I. ANTIMICROBIAL ACTIVITIES AND INHIBITION OF RNA AND PROTEIN SYNTHESIS.
Authors	CHANG,IM: HUR,SO: LEE,ES:
Year	1985
Volume
Issue

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (6)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AUCUBIN	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	AUCUBIN	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	AUCUBIN	ACTIVE
4	RNA SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	AUCUBIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CATALPOL	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CATALPOL	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	CATALPOL	ACTIVE
4	RNA SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	CATALPOL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GENIPOSIDE	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GENIPOSIDE	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	GENIPOSIDE	ACTIVE
4	RNA SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	GENIPOSIDE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GARDENOSIDE	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GARDENOSIDE	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	GARDENOSIDE	ACTIVE
4	RNA SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	GARDENOSIDE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SWERTIAMARIN	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SWERTIAMARIN	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	SWERTIAMARIN	ACTIVE
4	RNA SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	SWERTIAMARIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	REHMANNIOSIDE	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	REHMANNIOSIDE	ACTIVE
3	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	REHMANNIOSIDE	ACTIVE
4	RNA SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITRO	REHMANNIOSIDE	ACTIVE

Show SPARQL Queries (1)